However, given the incomplete recovery of the ocular abnormalities and the other symptoms, systemic treatment remains standard. © 2014 S. Karger AG, Basel
Case Report
A 50-year-old woman was referred to us for bilateral blurred vision as well as dryness and irritation of her eyes for several days. Except for a mild fatigue and a slight headache, she had no further complaints. Her visual acuity was 1.0 in both eyes, and slit-lamp examination was normal. A fundus examination revealed bilateral optic disc swelling and small preretinal peripapillary splinter haemorrhages in the right eye ( fig. 1a ). Her colour vision was normal (13/13 on Ishihara). Humphrey visual field testing showed an enlarged blind spot and an inferonasal deficit in both eyes (right > left) ( fig. 1 ). Fluorescein angiography demonstrated a bilateral late leakage of dye from the optic disc and pooling consistent with cystoid macular oedema (CMO) in the left eye. Non-perfused areas, intraretinal microvascular abnormalities and retinal neovascularizations were not seen. Optical coherence tomography (OCT) performed with Cirrus HD-OCT 6.0 showed an increased macular thickness with a small amount of subretinal fluid at the fovea in the left eye. In the right eye, the macular thickness was normal ( fig. 2 ). The segmentation algorithm was not used. The B-scan ultrasonography demonstrated disc swelling, but no drusen ( fig. 1 ).
General physical examination was normal except for absent ankle reflexes and a diminished sensation in the feet. Laboratory tests showed an erythrocyte sedimentation rate of 30 mm/h, elevated levels of M-protein type IgA of 1.4 g/l, and a vascular endothelial growth factor (VEGF) concentration of 6.1 ng/ml (n = 0.028-0.966 mg/l). Cerebrospinal fluid pressure was normal, and the cerebral spinal fluid had a protein content of 131 mg/dl (normal <45 mg/dl). An abdominal CT revealed hepatosplenomegaly. Her EMG showed a mild axonal sensorimotor polyneuropathy. The diagnosis of polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome was made based on polyneuropathy, hepatosplenomegaly, IgA lambda monoclonal proteinemia, and the optic disc swelling. Additional investigations to find a further possible malignancy revealed no abnormalities.
After 2 months, local treatment with 40 mg posterior sub-Tenon (PST) injection of triamcinolone in both eyes was started because of continuous complaints of blurred vision. This was followed by 2 intravitreal bevacizumab (IVB) injections of 2.5 mg in the left eye at intervals of 4 weeks after 10 weeks. Local therapy with PST injection had resulted in a small decrease of the optic disc swelling after 4 weeks. In the left eye, the macular oedema regressed, and the central retinal thickness, as measured by OCT, diminished. The IVB treatment resulted in a slight regression of the optic disc oedema (ODO) and a minimal decrease of the CMO (table 1). Because of diarrhoea and general malaise and the fact that the blurred vision had diminished but not completely disappeared, melphalan was initiated. This was followed by autologous peripheral blood stem cell transplantation. After systemic treatment, the patient had no further visual complaints and the ODO had disappeared ( fig.  3 ). The VEGF serum concentration normalized. Three years after the initial diagnosis, the patient's ophthalmological condition remained unchanged.
Discussion
POEMS syndrome is a rare and chronic paraneoplastic disorder characterized by polyneuropathy, organomegaly, endocrinopathy, M-protein and skin changes, resulting from an underlying plasma cell disorder. The acronym refers to some, but not all the features. POEMS syndrome is potentially fatal with a substantial deterioration in quality of life and a chronic clinical course [1, 2] . Eye involvement is characterized by ODO and CMO. Vision acuity is mostly normal. ODO, unilateral or bilateral, is present in 29-55% of patients [2, 3] . Macular oedema secondary to optic disc leakage is rare and associated with macular detachment [4, 5] . These patients usually report blurred vision [2] [3] [4] [5] [6] . In a study of 33 POEMS patients undergoing ophthalmologic examination, 5 patients reported diplopia, 15 patients had blurred vision, and 3 patients had ocular pain. Bilateral ODE was seen in about half of the cases, with about one third asymptomatic at the first examination [6] .
The pathogenesis of POEMS syndrome is not fully understood. An elevated production of proangiogenic and proinflammatory cytokines are believed to play a central role. VEGF and other cytokines are elevated, reflecting the clinical condition [1, 7] .
The mechanism underlying the formation of ODO and CMO associated with POEMS syndrome is unclear. ODO can result either from increased intracranial pressure or from a chronic overproduction of cytokines (such as VEGF) which supports extravascular volume overload secondary to raised vascular permeability [7] [8] [9] . Development of CMO might be attributed to the elevated serum VEGF and not to the VEGF secreted from retinal tissues [10] . ODO and CMO may result from an osmotic gradient created by the deposition of highmolecular-weight immunoglobulins within and beneath the neurosensory retina [7] .
Anti-VEGF antibodies such as bevacizumab are an effective treatment for ocular conditions associated with increased VEGF levels. Theoretically, they could also be used locally [1, 8] . Our case is the first in which bevacizumab was used intravitreally, resulting (in combination with PST injection) in a partial regression of ODO and CMO. ODO and CMO normalized however only after systemic treatment. Because POEMS is a systemic condition, the ocular inhibition of VEGF alone is insufficient. Additionally, decreasing VEGF serum concentration as a response to systemic treatment correlated with the resolving of optic disc swelling.
PST has been widely used in ophthalmology for the treatment of intraocular proliferative, oedematous, and neovascular diseases. A reduction of macular oedema can be induced by the anti-inflammatory reaction of steroids as investigated in several studies [9, 10] . In a case report describing pars plana vitrectomy and intraocular triamcinolone injections as a treatment for CMO, the macular thickness decreased. In the untreated eye, the macular thickness altered in relation to the serum VEGF level [11] .
In conclusion, local treatment with IVB and PST injection of triamcinolone can be an option for ocular symptoms in POEMS syndrome, but always in combination with the standard treatment of this syndrome.
Disclosure Statement
The authors declare no conflict of interest. 
